Stock Track | Westlake Chemical Plunges 14.69% in Pre-market on Disappointing Q1 Earnings

Stock Track05-05

Westlake Chemical's stock plummeted 14.69% in pre-market trading on Tuesday following the release of its first-quarter 2026 financial results, which significantly missed analyst expectations.

The chemical maker reported an adjusted loss of $0.77 per share for Q1 2026, which was much wider than the FactSet consensus estimate for a $0.10 non-GAAP loss per share. Net sales came in at $2.65 billion, falling short of the $2.76 billion estimate and representing a 6.82% decline compared to the same period last year.

The company's results were negatively impacted by several factors, including lower average sales prices across its business segments, charges related to litigation settlements and facility shutdowns, as well as higher natural gas costs. Westlake reported a Q1 net loss of $169 million and a pretax loss of $190 million, with an EBITDA margin of 9%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment